VitaSpring Biomedical Valuation
| VSBC Stock | USD 1.00 0.50 100.00% |
Today, the company appears to be fairly valued. VitaSpring Biomedical has a current Real Value of $1.0 per share. The regular price of the company is $1.0. Our model measures the value of VitaSpring Biomedical from inspecting the company fundamentals such as Operating Margin of 0.24 %, price to book of 1,622 X, and Return On Equity of 0.84 as well as reviewing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that VitaSpring Biomedical's price fluctuation is very steady at this time. Calculation of the real value of VitaSpring Biomedical is based on 3 months time horizon. Increasing VitaSpring Biomedical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since VitaSpring Biomedical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of VitaSpring Pink Sheet. However, VitaSpring Biomedical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0 | Real 1.0 | Hype 1.0 | Naive 1.0 |
The real value of VitaSpring Pink Sheet, also known as its intrinsic value, is the underlying worth of VitaSpring Biomedical Company, which is reflected in its stock price. It is based on VitaSpring Biomedical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of VitaSpring Biomedical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of VitaSpring Biomedical Co helps investors to forecast how VitaSpring pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of VitaSpring Biomedical more accurately as focusing exclusively on VitaSpring Biomedical's fundamentals will not take into account other important factors: VitaSpring Biomedical Total Value Analysis
VitaSpring Biomedical Co is at this time forecasted to have valuation of 2.89 B with market capitalization of 3.1 B, debt of 375.5 K, and cash on hands of 21.59 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the VitaSpring Biomedical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.89 B | 3.1 B | 375.5 K | 21.59 K |
VitaSpring Biomedical Investor Information
About 59.0% of the company outstanding shares are owned by insiders. The company had not issued any dividends in recent years. VitaSpring Biomedical had 5:1 split on the 29th of June 2020. VitaSpring Biomedical Co is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.VitaSpring Biomedical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. VitaSpring Biomedical has an asset utilization ratio of 155.75 percent. This indicates that the Company is making $1.56 for each dollar of assets. An increasing asset utilization means that VitaSpring Biomedical Co is more efficient with each dollar of assets it utilizes for everyday operations.VitaSpring Biomedical Ownership Allocation
VitaSpring Biomedical shows a total of 206.52 Million outstanding shares. VitaSpring Biomedical maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.VitaSpring Biomedical Profitability Analysis
The company reported the previous year's revenue of 5.61 M. Net Income was 1.26 M with profit before overhead, payroll, taxes, and interest of 2.06 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates VitaSpring Biomedical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in VitaSpring Biomedical and how it compares across the competition.
About VitaSpring Biomedical Valuation
The pink sheet valuation mechanism determines VitaSpring Biomedical's current worth on a weekly basis. Our valuation model uses a comparative analysis of VitaSpring Biomedical. We calculate exposure to VitaSpring Biomedical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of VitaSpring Biomedical's related companies.The company was formerly known as Shemn Corp. and changed its name to VitaSpring Biomedical Co. Ltd. was incorporated in 2016 and is headquartered in Irvine, California. Vitaspring Biomedical operates under Biotechnology classification in the United States and is traded on OTC Exchange.
8 Steps to conduct VitaSpring Biomedical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates VitaSpring Biomedical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct VitaSpring Biomedical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain VitaSpring Biomedical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine VitaSpring Biomedical's revenue streams: Identify VitaSpring Biomedical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research VitaSpring Biomedical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish VitaSpring Biomedical's growth potential: Evaluate VitaSpring Biomedical's management, business model, and growth potential.
- Determine VitaSpring Biomedical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate VitaSpring Biomedical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
VitaSpring Biomedical Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 206 M | |
| Quarterly Earnings Growth Y O Y | 0.167 | |
| Retained Earnings | 816.7 K | |
| Retained Earnings Total Equity | -816.7 K |
Complementary Tools for VitaSpring Pink Sheet analysis
When running VitaSpring Biomedical's price analysis, check to measure VitaSpring Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VitaSpring Biomedical is operating at the current time. Most of VitaSpring Biomedical's value examination focuses on studying past and present price action to predict the probability of VitaSpring Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VitaSpring Biomedical's price. Additionally, you may evaluate how the addition of VitaSpring Biomedical to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stocks Directory Find actively traded stocks across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |